He did it!
Tom Horton Walked 500 Miles for the FOXG1 Syndrome Gene Therapy!
A pilgrimage of prayer and action to bring hope to families worldwide
“The FOXG1 Research Foundation is on the road to delivering a groundbreaking gene therapy to children who urgently need it—and I’m walking the 500-mile Way of St. James pilgrimage to help move this treatment forward.
This is a journey about hope, faith, and the determination that together, we can rewrite what’s possible for children living with FOXG1 syndrome.”
Tom Horton
FOXG1 Research Foundation, Philanthropy Board Chairman; American Airlines, Former CEO; Global Infrastructure Partners, Partner
Watch Tom’s walk day-by-day - mile-by-mile
The Famous El Camino de Santiago “The Way”
For over a thousand years, pilgrims from around the world have journeyed the Camino de Santiago, a 500-mile path across northern Spain that leads to the resting place of St. James the Apostle in the Cathedral of Santiago de Compostela. According to tradition, St. James brought Christianity to the Iberian Peninsula and was laid to rest in Galicia after his martyrdom.
Since the 9th century, this ancient route has been walked as an act of devotion, healing, and reflection—each step representing sacrifice, hope, and faith.
The Camino has become a modern symbol of purpose and perseverance, beautifully portrayed by Martin Sheen in the film The Way.
Tom Horton—former CEO of American Airlines and FOXG1 grandfather—is walking the full 500 mile Camino on behalf of all the children with FOXG1 syndrome. The symbolism is profound: Tom is walking for children who, due to this devastating neurological genetic condition, cannot walk today—but who may be able to take steps of their own through the promise of gene therapy.
Join this mission. Every step brings us closer to a potentially life-changing treatment for children with FOXG1 syndrome, while paving the way to accelerate treatments for rare diseases around the world.
Over 32 days, Tom’s dedication and determination raised an incredible $1.2 million to help bring the FOXG1 gene therapy to children worldwide.
Thanks to this incredible support for Tom’s walk, the FOXG1 Gene Therapy “Yes, They Can!” campaign has reached the halfway mark — $11 million raised, with $11 million to go!
Thank you to everyone who donated, sponsored, or dedicated a mile to a FOXG1 child along the way. Together, you turned a single journey into a global effort for change and brought us many steps closer to a life-changing treatment for FOXG1 children everywhere.
You Are Helping Drive FOXG1 Gene Therapy to Children Around the World!
The “Yes, They Can!” campaign is raising $22 million to bring a promising gene therapy for children living with FOXG1 syndrome.
With every gift, you are helping move us closer to beginning patient trials in 2026—the first critical step toward making this treatment a reality.
Thank you to our “Yes, They Can!” campaign sponsors
Thank you to everyone who dedicated miles on behalf of children with FOXG1 Syndrome
Diego Amenabar
Truman Basso
Kiara-Ann Giovanna Brugnatti
Laura Debra Call
Everett Castro
Isaiah Cloyd
Hunter Cripe
Ofri Dar
Mirac Emir Dene
Refaeli Eitan Elbaz
Julia Estefanell Garcia
Ad Mikaela Goetz
Clarissa Faz
Zoi Flioura
Ivy Louise Gibbons
Oliver Giroud
Alba Gräll
Reuben Hansel
Harper Heublein
Parker Henriksen
Liliana Hibbits
Gianna Horton
Josie Johnson
Rylie Lacovara
Noah Lehmbeck
Aleena Muhammed Mahmood
Mykhailo Malytskyi
Rosato Marco
Corbin Menzia
Elijah Miree
Liza Katalin Molnár
Aaron Ben Naomi
Chiara Francienne G. Pantonial
Crosby Phillips
Margaret Popik
Mary Popik
Harper Fay Robertshaw
Daniel Rodríguez Mas
Trent Rogers
Mackenzie Elizabeth Scholtz
Tyler Trapnell
Cheyenne Tuckner
Eliza VanGelder,
Nico Ventosa
Abey Weitzman
Cricket Elizabeth Weldon
Christopher White
Elie Wu-Jakobsen
Park Yeseo
Amy Zgorski
Ben Zgorski
Every Step.
Every Donation Made to Power Tom’s 500 Mile walk brings us closer to helping so many children.
Thank you for being a FOXG1 Champion for a Cure.
Your belief in us will lead to incredible improvements for countless children with rare disorders.